| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.087 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |